Finally, IRE1 has been proven to be a key interactor involved in NF-κB activation [114,115] and might have a fundamental role in metabolic syndrome and lipid disorders [116], regenerative myogenesis [117], or cardiac diseases [118]. This evidence concerns the gene NFKB1 and metabolic syndrome.